LGC Capital, Ltd., update on Trichomed, Quebec

World News: . []

MONTREAL, July 12, 2019 (GLOBE NEWSWIRE) --  

LGC Capital Ltd. (“LGC” or the “Company”), has been advised that it has been served by Trichomed Corporation ("Trichomed") with a motion for a declaratory judgement whereby Trichomed  is seeking the cancellation of the convertible debenture (the "Debenture") it entered into with the Company in December of 2017 and to repay the entire amount advanced by LGC representing four million dollars plus the interest accrued thereon. Under the terms of the Debenture, upon Trichomed receiving its license to cultivate cannabis from Health Canada, the loan amount shall be converted into that number of common shares of Trichomed equivalent to 49% of Trichomed's capital on a fully diluted basis together with a 5% net sales royalty on all of Trichomed's future revenues.

Mazen Haddad, CEO stated, “We believe that this action from Trichomed is without merit and LGC is well within its rights to continue to hold its position with its investment in Trichomed while we await approval from Health Canada.  We are confident that we will resolve this matter as quickly as possible and in the best interest of our shareholders.”

Mark Shinners, Chief Financial OfficerTel: +44 7827 960971

More news and information about LGC Capital LTD.

Published By:

Globe Newswire: 14:30 GMT Friday 12th July 2019

Published: .

Search for other references to "capital" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us